Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment
This study has been completed.
Study NCT00133848   Information provided by GlaxoSmithKline

First Received on August 22, 2005.   Last Updated on March 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Impetigo
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Skin Diseases
Skin Diseases, Bacterial
Skin Diseases, Infectious
Staphylococcal Infections
Staphylococcal Skin Infections
Streptococcal Infections
Interventions listed in this trial
SB-275833 ointment, 1%
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services